Evidence map›Paper›PMID 37439842›Full record

ArticleHandbook of experimental pharmacology2023

Clinical Pharmacological Considerations in Transgender Medicine.

Rene Coig, Victoria Luna Brennan Grieve, Lauren R Cirrincione

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Handbook of experimental pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rene CoigDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Victoria Luna Brennan GrieveDepartment of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA.
Lauren R CirrincioneDepartment of Pharmacy, University of Washington, Seattle, WA, USA. lc10@uw.edu.

Funding

Biological Mechanisms of Healthy Aging Training GrantT32AG066574 · NIA · UNIVERSITY OF WASHINGTON · PI David J. Marcinek, Jessica E Young · 2020 to 2026
$5.3M
Hormone mediated mechanisms of altered drug metabolism and transport in transgender adultsK23GM147350 · NIGMS · UNIVERSITY OF WASHINGTON · PI CIRRINCIONE, LAUREN · 2022 to 2025
$748k
NIA NIH HHS T32 AG066574NIGMS NIH HHS K23 GM147350
6 · The paper itself

Abstract

Transgender medicine is a growing clinical field. Hormone therapy (testosterone or estrogen treatment) is part of the standard of gender-affirming medical care, yet clinical pharmacological knowledge in transgender medicine is lacking. Herein, we summarize available clinical and pharmacologic data for hormone therapy among transgender and gender diverse people.

Indexed as

Drug interactionsDrug-metabolizing enzymesDrug transport proteinsGender-affirming medical carePharmacologySex steroid hormonesTransgender

Identifiers

PMID37439842
PMCPMC11162826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.